NLNK Share Price

Open 19.76 Change Price %
High 20.48 1 Day 0.30 1.49
Low 19.65 1 Week -0.26 -1.26
Close 20.39 1 Month 4.68 29.79
Volume 155519 1 Year 3.73 22.39
52 Week High 22.92
52 Week Low 9.23
NLNK Important Levels
Resistance 2 21.16
Resistance 1 20.84
Pivot 20.17
Support 1 19.94
Support 2 19.62
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
ASTI 0.00 0.00%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
MU 28.76 1.16%
MU 28.76 1.16%
MU 28.76 1.16%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
LOCM 0.09 50.00%
IPXL 12.70 37.30%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
RGLS 1.70 21.43%
SCON 1.54 19.38%
CPRX 2.01 18.24%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

NewLink Genetics Corporation (NASDAQ: NLNK)

NLNK Technical Analysis 5
As on 27th Mar 2017 NLNK Share Price closed @ 20.39 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 12.79 & Strong Buy for SHORT-TERM with Stoploss of 15.67 we also expect STOCK to react on Following IMPORTANT LEVELS.
NLNK Target for March
1st Target up-side 18.48
2nd Target up-side 20.42
3rd Target up-side 22.36
1st Target down-side 12.94
2nd Target down-side 11
3rd Target down-side 9.06
NLNK Other Details
Segment EQ
Market Capital 281938752.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.newlinkgenetics.com
NLNK Address
NLNK
2503 South Loop Drive
Ames, IA 50010
United States
Phone: 515-296-5555
Fax: 515-296-3520
NLNK Latest News
Interactive Technical Analysis Chart NewLink Genetics Corporation ( NLNK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on NewLink Genetics Corporation
NLNK Business Profile
NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians. Its HyperAcute cancer immunotherapies aim to treat non-small cell lung cancer, pancreatic cancer, melanoma, prostate cancer, and breast cancer.